Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 15Completed 4Active not recruiting 4Not yet recruiting 3Terminated 1Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Kidney Diseases 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 67Cyclophosphamide 45Cisplatin 45Nivolumab 39Paclitaxel 35Carboplatin 31Radiotherapy 30Gemcitabine 28Docetaxel 27Dexamethasone 23atezolizumab 22Bevacizumab 20Doxorubicin 19Vincristine 17Magnetic Resonance Spectroscopy 17Lenalidomide 17fludarabine 16Radiosurgery 16Fluorouracil 16Etoposide 16Blood Specimen Collection 16Rituximab 15Radiation 15Letrozole 15Irinotecan 15Ipilimumab 15palbociclib 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × spartalizumab × 90 days × Clear all
NCT05213884 2026-04-24

The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC

Chongqing University Cancer Hospital

Phase 2 Completed
39 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04028245 2026-04-15

SPARC-1

Columbia University

Phase EARLY_PHASE1 Completed
17 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02964078 2026-04-02

Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
27 enrolled 10 charts
Genitourinary

Kidney Diseases, Kidney Neoplasms, Neoplasm Metastasis

NCT03568058 2026-03-24

Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers

University of California, San Diego

Phase 1 Completed
25 enrolled 12 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡